-+ 0.00%
-+ 0.00%
-+ 0.00%

TRAVERE THERAPEUTICS, INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $67 FROM $78

Reuters·11/03/2026 12:10:54

Please log in to view news